These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

926 related articles for article (PubMed ID: 17591692)

  • 21. The aryl hydrocarbon receptor activates the retinoic acid receptoralpha through SMRT antagonism.
    Widerak M; Ghoneim C; Dumontier MF; Quesne M; Corvol MT; Savouret JF
    Biochimie; 2006; 88(3-4):387-97. PubMed ID: 16480812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroanatomical distribution and colocalisation of nuclear receptor corepressor (N-CoR) and silencing mediator of retinoid and thyroid receptors (SMRT) in rat brain.
    van der Laan S; Lachize SB; Schouten TG; Vreugdenhil E; de Kloet ER; Meijer OC
    Brain Res; 2005 Oct; 1059(2):113-21. PubMed ID: 16212947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells.
    Sarvilinna N; Eronen H; Miettinen S; Vienonen A; Ylikomi T
    Int J Cancer; 2006 Feb; 118(4):832-40. PubMed ID: 16152593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of nuclear receptor corepressor (N-CoR) expression levels on retinoic acid receptor-mediated repression support the existence of dynamically regulated corepressor complexes.
    Söderström M; Vo A; Heinzel T; Lavinsky RM; Yang WM; Seto E; Peterson DA; Rosenfeld MG; Glass CK
    Mol Endocrinol; 1997 Jun; 11(6):682-92. PubMed ID: 9171232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists.
    Huang HJ; Norris JD; McDonnell DP
    Mol Endocrinol; 2002 Aug; 16(8):1778-92. PubMed ID: 12145334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells.
    Lu M; Mira-y-Lopez R; Nakajo S; Nakaya K; Jing Y
    Oncogene; 2005 Jun; 24(27):4362-9. PubMed ID: 15870697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
    Huynh KD; Bardwell VJ
    Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
    Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
    Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional analyses of an LXXLL motif in nuclear receptor corepressor (N-CoR).
    Loinder K; Söderström M
    J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):191-6. PubMed ID: 15336696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of SMRT corepressor in transcriptional repression by the vitamin D receptor.
    Kim JY; Son YL; Lee YC
    Mol Endocrinol; 2009 Feb; 23(2):251-64. PubMed ID: 19098224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear corepressor is required for inhibition of phosphoenolpyruvate carboxykinase expression by tumor necrosis factor-alpha.
    Yan J; Gao Z; Yu G; He Q; Weng J; Ye J
    Mol Endocrinol; 2007 Jul; 21(7):1630-41. PubMed ID: 17456789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
    Laganière J; Deblois G; Giguère V
    Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence.
    Smith CL; Migliaccio I; Chaubal V; Wu MF; Pace MC; Hartmaier R; Jiang S; Edwards DP; Gutiérrez MC; Hilsenbeck SG; Oesterreich S
    Breast Cancer Res Treat; 2012 Nov; 136(1):253-65. PubMed ID: 23015261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recruitment of N-CoR/SMRT-TBLR1 corepressor complex by unliganded thyroid hormone receptor for gene repression during frog development.
    Tomita A; Buchholz DR; Shi YB
    Mol Cell Biol; 2004 Apr; 24(8):3337-46. PubMed ID: 15060155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corepressor SMRT functions as a coactivator for thyroid hormone receptor T3Ralpha from a negative hormone response element.
    Berghagen H; Ragnhildstveit E; Krogsrud K; Thuestad G; Apriletti J; Saatcioglu F
    J Biol Chem; 2002 Dec; 277(51):49517-22. PubMed ID: 12388540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
    Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p27(Kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells.
    Carroll JS; Lynch DK; Swarbrick A; Renoir JM; Sarcevic B; Daly RJ; Musgrove EA; Sutherland RL
    Cancer Res; 2003 Aug; 63(15):4322-6. PubMed ID: 12907598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Augmentation of estrogen receptor-mediated transcription by steroid and xenobiotic receptor.
    Rokutanda N; Iwasaki T; Odawara H; Nagaoka R; Miyazaki W; Takeshita A; Koibuchi Y; Horiguchi J; Shimokawa N; Iino Y; Morishita Y; Koibuchi N
    Endocrine; 2008 Jun; 33(3):305-16. PubMed ID: 19011999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The silencing mediator of retinoic acid and thyroid hormone receptors can interact with the aryl hydrocarbon (Ah) receptor but fails to repress Ah receptor-dependent gene expression.
    Rushing SR; Denison MS
    Arch Biochem Biophys; 2002 Jul; 403(2):189-201. PubMed ID: 12139968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear receptor coregulators differentially modulate induction and glucocorticoid receptor-mediated repression of the corticotropin-releasing hormone gene.
    van der Laan S; Lachize SB; Vreugdenhil E; de Kloet ER; Meijer OC
    Endocrinology; 2008 Feb; 149(2):725-32. PubMed ID: 18006628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.